These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 12428241

  • 1. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [Abstract] [Full Text] [Related]

  • 2. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MH, Barr W, Moreland LW, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold JR.
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [Abstract] [Full Text] [Related]

  • 3. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial.
    Clements PJ, Hurwitz EL, Wong WK, Seibold JR, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE.
    Arthritis Rheum; 2000 Nov; 43(11):2445-54. PubMed ID: 11083267
    [Abstract] [Full Text] [Related]

  • 4. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis.
    Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin R, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold J.
    Arthritis Rheum; 1999 Nov; 42(11):2372-80. PubMed ID: 10555033
    [Abstract] [Full Text] [Related]

  • 5. The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trial.
    Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, Wigley F, Weisman M, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Seibold JR.
    Arthritis Rheum; 2001 Mar; 44(3):653-61. PubMed ID: 11263780
    [Abstract] [Full Text] [Related]

  • 6. Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.
    Steen VD, Medsger TA.
    Arthritis Rheum; 1998 Sep; 41(9):1613-9. PubMed ID: 9751093
    [Abstract] [Full Text] [Related]

  • 7. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF, Pope JE, Ouimet JM.
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [Abstract] [Full Text] [Related]

  • 8. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE.
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [Abstract] [Full Text] [Related]

  • 9. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
    Teixeira L, Mouthon L, Mahr A, Berezné A, Agard C, Mehrenberger M, Noël LH, Trolliet P, Frances C, Cabane J, Guillevin L, Group Français de Recherche sur le Sclérodermie (GFRS).
    Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
    [Abstract] [Full Text] [Related]

  • 10. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD, Medsger TA.
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [Abstract] [Full Text] [Related]

  • 11. Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    Strand V.
    Arthritis Rheum; 2002 Nov; 46(11):2836-7. PubMed ID: 12428222
    [No Abstract] [Full Text] [Related]

  • 12. Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
    Mayes MD, O'Donnell D, Rothfield NF, Csuka ME.
    Arthritis Rheum; 2004 Feb; 50(2):553-7. PubMed ID: 14872498
    [Abstract] [Full Text] [Related]

  • 13. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP, Gilkeson GS, Pyun EH, Pisetsky DS, Smith EA, Simon LS.
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [Abstract] [Full Text] [Related]

  • 14. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
    Sultan N, Pope JE, Clements PJ, Scleroderma Trials Study Group.
    Rheumatology (Oxford); 2004 Apr; 43(4):472-8. PubMed ID: 14679295
    [Abstract] [Full Text] [Related]

  • 15. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S, Harding S, Bonner A, Zummer B, Baron M, Pope J, Canadian Scleroderma Research Group.
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [Abstract] [Full Text] [Related]

  • 16. Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases.
    Gündüz OH, Fertig N, Lucas M, Medsger TA.
    Arthritis Rheum; 2001 Jul; 44(7):1663-6. PubMed ID: 11465718
    [Abstract] [Full Text] [Related]

  • 17. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
    Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA, Rietschel RL, Wintroub B, Kahaleh MB, Varga J.
    Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
    [Abstract] [Full Text] [Related]

  • 18. Scleroderma renal crisis: patient characteristics and long-term outcomes.
    Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, Burns A, Denton CP.
    QJM; 2007 Aug; 100(8):485-94. PubMed ID: 17601770
    [Abstract] [Full Text] [Related]

  • 19. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P.
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [Abstract] [Full Text] [Related]

  • 20. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research group, Baron M, Pope J.
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.